Treatment News : Tenofovir-Laced Vaginal Ring Protects Monkeys Against Simian HIV

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » March 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

March 26, 2013

Tenofovir-Laced Vaginal Ring Protects Monkeys Against Simian HIV

An intravaginal ring infused with the HIV antiretroviral tenofovir protected six out of six macaque monkeys from repeated exposures to simian HIV (SHIV), the National AIDS Treatment Advocacy Project (NATAP) reports. Presenting their findings at the 20th Conference on Retroviruses and Opportunistic Infections (CROI) in Atlanta, researchers from the Centers for Disease Control and Prevention (CDC) and other institutions manufactured a ring infused with tenofovir that administered an average of 2.3 milligrams of the drug each day. They then inserted the ring into the vaginas of six monkeys, replacing it every 28 days.

The investigators vaginally exposed the six monkeys as well as 12 control primates to SHIV once a week for up to 16 weeks. Eleven of the control monkeys became infected with the virus after a median four exposures. None of the monkeys with the intravaginal rings were infected. The rings proved well tolerated across five months of study.  

The researchers have imminent plans to begin a Phase I trial of the ring in humans.

To read the NATAP report, click here.

To read the conference abstract, click here.

Search: HIV, SHIV, simian, monkey, macaque, National AIDS Treatment Advocacy Project, NATAP, 20th Conference on Retroviruses and Opportunistic Infections, CROI, Centers for Disease Control and Prevention, CDC, tenofovir, intravaginal ring.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    fokisi
    Long Beach
    California


    RyGuy00
    New York
    New York


    TaintedloveDC
    Washington
    DC


    jacob2608
    Panama City Beach
    Florida
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Is HIV/AIDS adequately portrayed in pop culture?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.